Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety, tolerability and efficacy of CT1812 in adults with mild to moderate dementia with Lewy bodies has completed and posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia with Lewy Bodies

Drugs mentioned

• CT1812

Snippet

Sponsor: Cognition Therapeutics | Conditions: Dementia With Lewy Bodies | Phase 2 | Status: COMPLETED | Results posted: 2026-03-12